S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Collection of Tissue Samples for Cancer Research
- Status
- RECRUITING
- Phase
- N/A
Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
- Status
- COMPLETED
- Phase
- PHASE2
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- Status
- RECRUITING
- Phase
- N/A
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
- Status
- COMPLETED
- Phase
- PHASE2
Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?
- Status
- COMPLETED
- Phase
- NA
Single Autologous Stem Cell Transplantation Followed by Maintenance Therapy as Front-line Treatment for Myeloma
- Status
- SUSPENDED
- Phase
- PHASE3
Umbilical Cord Blood Transplant for Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of 25mg Versus 5 mg Lenalidomide as Maintenance Therapy in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Dose-escalation Study of Oral CX-4945
- Status
- UNKNOWN
- Phase
- PHASE1
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Panobinostat/Velcade in Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols
- Status
- COMPLETED
- Phase
- PHASE2
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
- Status
- COMPLETED
- Phase
- N/A
A Study of Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients
- Status
- UNKNOWN
- Phase
- PHASE3
PHA-739358 for the Treatment of Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630)
- Status
- COMPLETED
- Phase
- PHASE1
Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6)
- Status
- COMPLETED
- Phase
- PHASE1